Skip to main content
. 2011 Dec 2;6(12):e26783. doi: 10.1371/journal.pone.0026783

Figure 6. Cost-effectiveness .

Figure 6

Results by Gender, Genotype 1 under Triple Therapy with Telaprevir: (A) Men; (B) Women.